Ectopic pregnancy - Nursing Case Study

Pathophysiology

• Primary mechanism: Ectopic pregnancy occurs when a fertilized egg implants outside the uterus, most commonly in the fallopian tube. This is often due to scarring or blockage in the tube, which can be caused by previous infections, surgeries, or conditions like endometriosis.

• Secondary mechanism: The abnormal implantation site lacks the ability to support pregnancy growth, leading to the stretching and potential rupture of surrounding tissues. This can result in bleeding and damage to the reproductive organs.

• Key complication: If the ectopic pregnancy continues to grow, it can cause the structure it's implanted in, such as the fallopian tube, to burst, leading to severe internal bleeding, a medical emergency that requires immediate attention.

Patient Profile

Demographics:

28-year-old female, office manager

History:

• Key past medical history: No significant past medical history

• Current medications: Oral contraceptive pills

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Mild lower abdominal pain

• Key symptoms: Spotting, mild lower abdominal discomfort, last menstrual period 6 weeks ago

• Vital signs: Blood pressure 118/76 mmHg, heart rate 78 bpm, respiratory rate 16 breaths per minute, temperature 98.6°F (37°C)

Section 1

Initial Assessment Findings:

Upon conducting the initial assessment, the nurse notes that the patient's mild lower abdominal pain is localized to the right side. The patient rates the pain as a 4 out of 10 on the pain scale. She reports intermittent spotting since the onset of the abdominal discomfort, which she initially attributed to an irregular menstrual cycle. A physical examination reveals mild tenderness in the right lower quadrant, but no guarding or rebound tenderness is observed. The patient's abdomen is soft, and bowel sounds are present in all quadrants. There is no evidence of significant distention or rigidity.

The nurse also conducts a basic assessment of the patient's emotional state, finding her to be mildly anxious due to the unexplained nature of her symptoms. She denies experiencing any nausea or vomiting and has no history of similar pain episodes. Given the presentation, the nurse suspects a possible ectopic pregnancy and prioritizes obtaining a serum beta-hCG level to confirm pregnancy and an ultrasound to determine the location of the gestational sac. The patient is reassured and educated about the importance of timely diagnosis and management to prevent potential complications.

Section 2

New Diagnostic Results:

Following the initial assessment, the nurse receives the results of the serum beta-hCG test, which confirms the presence of pregnancy with a level consistent with early gestation. An urgent transvaginal ultrasound is performed to visualize the gestational sac. The imaging reveals that the gestational sac is located in the right fallopian tube, confirming the diagnosis of an ectopic pregnancy. No free fluid is observed in the pelvis, indicating the absence of significant internal bleeding at this stage.

The patient's vital signs remain stable with a blood pressure of 118/76 mmHg, heart rate of 78 beats per minute, respiratory rate of 16 breaths per minute, and temperature at 98.6°F. Her oxygen saturation is 99% on room air. The nurse communicates the findings to the patient, explaining the diagnosis of an ectopic pregnancy and discussing the implications. The patient is informed of the need for medical intervention to resolve the ectopic pregnancy and prevent further complications. She expresses understanding but remains anxious about the situation. The nurse provides emotional support and reassurance, outlining the next steps in care. A plan is made for the patient to consult with the physician regarding potential treatment options, which may include medical management with methotrexate, given the early stage of the ectopic pregnancy and the patient's stable condition.

Section 3

As the patient prepares to meet with the physician to discuss treatment options for her ectopic pregnancy, the nurse continues to monitor her condition closely. During a routine assessment, the nurse notices that the patient is experiencing mild, intermittent abdominal discomfort, primarily localized to the right lower quadrant. The patient rates her pain as a 3 out of 10 on the pain scale, describing it as a dull ache. She denies any new symptoms such as dizziness, shoulder pain, or increased bleeding, which suggests that her condition remains stable. Her vital signs are reassessed, showing a blood pressure of 116/74 mmHg, a heart rate of 80 beats per minute, a respiratory rate of 17 breaths per minute, and an oxygen saturation of 98% on room air. The nurse documents these findings and prepares to relay them to the attending physician.

In light of the patient's stable condition and early-stage ectopic pregnancy, the physician discusses the option of medical management with methotrexate. The nurse takes the opportunity to educate the patient about the medication, explaining that methotrexate works by stopping the growth of rapidly dividing cells, which can resolve the ectopic pregnancy without the need for surgery. The patient is informed that this treatment option is typically successful in early, uncomplicated cases and is associated with fewer risks than surgical intervention. The nurse also outlines the importance of follow-up appointments to monitor beta-hCG levels, which should decrease as the methotrexate effectively resolves the ectopic pregnancy.

The patient expresses relief at having a non-surgical option and agrees to proceed with the methotrexate treatment. The nurse provides instructions about potential side effects, such as nausea and mild abdominal pain, and emphasizes the importance of reporting any severe symptoms immediately. The patient is encouraged to rest and avoid strenuous activities while the treatment takes effect. With a clear care plan in place and continuous support from the healthcare team, the patient feels more at ease as she begins the next phase of her treatment journey.

Section 4

Several days after beginning methotrexate treatment, the patient returns for a follow-up appointment. During this visit, the nurse conducts an initial assessment to evaluate the patient's response to the intervention. The patient reports experiencing mild nausea but denies any severe abdominal pain or new symptoms such as dizziness or vaginal bleeding. Her pain remains localized to the right lower quadrant and is consistent with previous evaluations, rated at a 2 out of 10. Vital signs are assessed, revealing a blood pressure of 114/72 mmHg, a heart rate of 78 beats per minute, a respiratory rate of 16 breaths per minute, and an oxygen saturation of 99% on room air. These findings suggest that the patient is maintaining stable vital signs and experiencing no acute distress.

The nurse then reviews the latest laboratory results, which show a decrease in the patient's beta-hCG levels, indicating that the methotrexate is effectively stopping the growth of the ectopic pregnancy tissue. This decline in beta-hCG is a positive sign that the treatment is working as intended. The nurse explains these results to the patient, reinforcing the importance of ongoing monitoring and adherence to follow-up appointments. The patient is advised to continue avoiding strenuous activities and to report any new or worsening symptoms immediately.

Reassured by the positive progress and steady condition, the patient expresses gratitude for the clear communication and support from the healthcare team. The nurse emphasizes the importance of continued vigilance and rest, as well as maintaining a healthy diet to support recovery. With a solid understanding of her care plan and confidence in her treatment path, the patient leaves the clinic feeling optimistic about her recovery and the resolution of her ectopic pregnancy.

Section 5

A week later, the patient returns for another follow-up appointment as part of her ongoing management for the ectopic pregnancy. During this visit, the nurse conducts a thorough assessment to ensure continued progress and to identify any new complications. The patient reports feeling slightly fatigued but attributes it to her recent adjustments in daily activities to allow more rest. She denies any new symptoms such as increased abdominal pain, dizziness, or vaginal bleeding. Her localized pain in the right lower quadrant remains mild and unchanged, rated at a 2 out of 10. Vital signs are stable, with a blood pressure of 112/74 mmHg, a heart rate of 76 beats per minute, a respiratory rate of 16 breaths per minute, and an oxygen saturation of 98% on room air. These stable vital signs indicate that the patient is not in acute distress and is responding well to the treatment.

The nurse reviews the latest laboratory results, noting a further decrease in the patient's beta-hCG levels, which is a reassuring sign that the methotrexate treatment continues to be effective. However, the nurse also observes a slight decrease in the patient's hemoglobin levels, dropping from 12.5 g/dL to 11.8 g/dL. While this change is minor, it prompts the nurse to discuss the importance of monitoring for signs of anemia, such as increased fatigue or pallor, and to encourage the patient to maintain adequate iron intake through her diet. The nurse explains these findings to the patient, emphasizing that her condition is still stable but requires ongoing observation to ensure no further complications arise.

The patient leaves the clinic reassured by the continued positive trend in her treatment but remains mindful of the need for vigilance regarding any new symptoms. She expresses appreciation for the detailed guidance and support from the healthcare team and commits to adhering to the follow-up schedule. With a clear understanding of her care plan and the encouragement of her progress, the patient remains optimistic about her recovery and the resolution of her ectopic pregnancy.